0001593968-24-000003.txt : 20240102
0001593968-24-000003.hdr.sgml : 20240102
20240102162924
ACCESSION NUMBER: 0001593968-24-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brockstedt Dirk G.
CENTRAL INDEX KEY: 0001635616
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 24502851
MAIL ADDRESS:
STREET 1: C/O ADURO BIOTECH, INC.
STREET 2: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
primary_01.xml
PRIMARY DOCUMENT
X0508
4
2023-12-29
0001673772
RAPT Therapeutics, Inc.
RAPT
0001635616
Brockstedt Dirk G.
C/O RAPT THERAPEUTICS, INC.,
561 ECCLES AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Scientific Officer
false
Common Stock
2023-12-29
4
M
false
8000
6.18
A
27070
D
Employee Stock Option (right to buy)
6.18
2023-12-29
4
M
false
8000
0
A
2028-03-27
Common Stock
8000
7690
D
Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
/s/ Rodney Young, Attorney-in-Fact for Dirk G Brockstedt
2024-01-02